ecancermedicalscience

ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.

The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.

Editor-in-Chief: Dr Enrique Soto Pérez de Celis MD, PhD, FASCO

ISSN: 1754-6605

Submit article

892-conservative-treatment-for-well-differentiated-endometrial-cancer-when-and-why-it-should-be-considered-in-young-women

Review: Conservative treatment for well-differentiated endometrial cancer: when and why it should be considered in young women

Michele Peiretti, Francesca Congiu, Enzo Ricciardi, Paolo Maniglio, Valerio Mais, Stefano Angioni

17 Jan 2019

https://doi.org/10.3332/ecancer.2019.892

Abstract | Full Article | PDF

891-proteomics-characterisation-of-central-nervous-system-metastasis-biomarkers-in-triple-negative-breast-cancer

Research: Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer

Katerin Rojas L, Lucía Trilla-Fuertes, Angelo Gámez-Pozo, Cristina Chiva, Juan Sepúlveda, Luis Manso, Guillermo Prado-Vázquez, Andrea Zapater-Moros, Rocío López-Vacas, María Ferrer-Gómez, César Mendiola, Enrique Espinosa, Eduard Sabidó, Eva Ciruelos, Juan Ángel Fresno Vara

15 Jan 2019

https://doi.org/10.3332/ecancer.2019.891

Abstract | Full Article | PDF

890-anticancer-response-to-disulfiram-may-be-enhanced-by-co-treatment-with-mek-inhibitor-or-oxaliplatin-modulation-by-tetrathiomolybdate-kras-braf-mutations-and-c-myc-p53-status

Research: Anticancer response to disulfiram may be enhanced by co-treatment with MEK inhibitor or oxaliplatin: modulation by tetrathiomolybdate, KRAS/BRAF mutations and c-MYC/p53 status

Ali Calderon-Aparicio, Alejandro Cornejo, Andrea Orue, Manuel Rieber

8 Jan 2019

https://doi.org/10.3332/ecancer.2019.890

Abstract | Full Article | PDF

889-the-cardioprotective-effect-of-dexrazoxane-cardioxane-is-consistent-with-sequestration-of-poly-adp-ribose-by-self-assembly-and-not-depletion-of-topoisomerase-2b

Research: The cardioprotective effect of dexrazoxane (Cardioxane) is consistent with sequestration of poly(ADP-ribose) by self-assembly and not depletion of topoisomerase 2B

Keith McCormack

21 Dec 2018

https://doi.org/10.3332/ecancer.2018.889

Abstract | Full Article | PDF

888-spontaneous-testicular-tumor-regression-case-report-and-historical-review

Review: Spontaneous testicular tumor regression: case report and historical review

Juan C Astigueta, Milagros A Abad-Licham, Folker M Agreda, Benjamin A Leiva, Jorge L De La Cruz

18 Dec 2018

https://doi.org/10.3332/ecancer.2018.888

Abstract | Full Article | PDF | Spanish

887-palliative-splenic-irradiation-for-symptomatic-splenomegaly-in-non-hodgkin-lymphoma

Case Report: Palliative splenic irradiation for symptomatic splenomegaly in non-Hodgkin lymphoma

Liliana Castro Oliveira, Carlos Fardilha, Manuel Louro, Carlos Pinheiro, Abílio Sousa, Herlander Marques, Paulo Costa

13 Dec 2018

https://doi.org/10.3332/ecancer.2018.887

Abstract | Full Article | PDF

886-redo-db-the-repurposing-drugs-in-oncology-database

Research: ReDO_DB: the repurposing drugs in oncology database

Pan Pantziarka, Ciska Verbaanderd, Vidula Sukhatme, Rica Capistrano, Sergio Crispino, Bishal Gyawali, Ilse Rooman, An MT Van Nuffel, Lydie Meheus, Vikas P Sukhatme, Gauthier Bouche

6 Dec 2018

https://doi.org/10.3332/ecancer.2018.886

Abstract | Full Article | PDF

885-fertility-preservation-in-ovarian-tumours

Review: Fertility preservation in ovarian tumours

Federica Tomao, Anna Di Pinto, Carolina Maria Sassu, Erlisa Bardhi, Violante Di Donato, Ludovico Muzii, Maria Cristina Petrella, Fedro Alessandro Peccatori, Pierluigi Benedetti Panici

6 Dec 2018

https://doi.org/10.3332/ecancer.2018.885

Abstract | Full Article | PDF